used in traditional Chinese, Ayurvedic, and Thai medication. Conolidine could represent the beginning of a new era of Serious discomfort management. It is now becoming investigated for its outcomes to the atypical chemokine receptor (ACK3). In a rat model, it was observed that a competitor molecule binding to ACKR3 resulted in inhibition of ACKR3�